Form 4 for CALC CalciMedica, Inc.

Accepted 2024-11-05 00:00:00 ET · period of report 2024-11-01 · accession 0001415889-24-026102 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
	2024-11-05	2024-11-01	CALC	MIDDLETON FRED A	Dir, 10%	P - Purchase	$3.75	+20.0K	31.7K	+171%	+$75.0K
MI	2024-11-05	2024-11-01	CALC	MIDDLETON FRED A	Dir, 10%	P - Purchase	$3.75	+87.7K	22.5K	New	+$329.0K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2024-11-01	P	A	20,000	$3.75	31,714	D	—	—
2	Common	Common Stock	2024-11-01	P	A	86,867	$3.75	814,300	I By Sanderling Venture Partners VI Co-Investment Fund, L.P.	—	—	(F1) The Reporting Person, a director of Sanderling Ventures, may be deemed to beneficially own the securities of the Issuer held by Sanderling Venture Partners VI Co-Investment Fund, LP ("SVP VI Co-Investment, LP", together with Sanderling Venture Partners VI, LP., Sanderling VI Beteiligungs GmbH & Co. KG, Sanderling Ventures Management VI and Sanderling VI Limited Partnership (the "Sanderling VI Securities"). The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
3	Common	Common Stock	2024-11-01	P	A	877	$3.75	22,479	I By Sanderling Ventures Management VI	—	—	(F2) The Reporting Person, a director of Sanderling Ventures, may be deemed to beneficially own the Sanderling VI Securities. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.